RITA GUSMÃO DE NORONHA,CARLA PATRÍCIA DA COSTA PEREIRA ROSA,LASZLO ERNO KISS,PATRÍCIO MANUEL VIEIRA ARAÚJO SOARES DA SILVA,DOMENICO RUSSO,JORGE BRUNO REIS WAHNON,WILLIAM MATON
申请号：
PT13750166
公开号：
PT2890684T
申请日:
2013.07.24
申请国别(地区):
PT
年份:
2018
代理人:
摘要：
A compound having the following structure: or a pharmaceutically acceptable salt or derivative thereof. The compound may be used in the treatment or prevention of a disorder selected from appetite regulation, obesity, metabolic disorders, cachexia, anorexia, pain, inflammation, neurotoxicity, neurotrauma, stroke, multiple sclerosis, spinal cord injury, Parkinsons disease, levodopa-induced dyskinesia, Huntingtons disease, Gilles de la Tourettes syndrome, tardive dyskinesia, dystonia, amyotrophic lateral sclerosis, Alzheimers disease, epilepsy, schizophrenia, anxiety, depression, insomnia, nausea, emesis, alcohol disorders, drug addictions such as opiates, nicotine, cocaine, alcohol and psychostimulants, hypertension, circulatory shock, myocardial reperfusion injury, atherosclerosis, asthma, glaucoma, retinopathy, cancer, inflammatory bowel disease, acute and chronic liver disease such as hepatitis and liver cirrhosis, arthritis and osteoporosis.
